Regulation of osteoclastogenesis by integrated signals from toll-like receptors

Journal of Cellular Biochemistry

Volumn 115, Issue 12, 2014, Pages 2146-2154

  Krisher, Tamar ^a   Bar Shavit, Zvi ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

c Fos; M CSFR; OSTEOCLAST; TOLL LIKE RECEPTORS

Indexed keywords

COLONY STIMULATING FACTOR 1; CPG OLIGODEOXYNUCLEOTIDE; DOUBLE STRANDED RNA; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; OSTEOCLAST DIFFERENTIATION FACTOR; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN C FOS; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; COLONY STIMULATING FACTOR RECEPTOR; CPG-OLIGONUCLEOTIDE; OLIGODEOXYRIBONUCLEOTIDE; TNFSF11 PROTEIN, MOUSE; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; INFLAMMATORY CELL; MALE; MODULATION; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; OUTER MEMBRANE; PRIORITY JOURNAL; REGULATORY MECHANISM; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; GENE EXPRESSION; METABOLISM; OSTEOCLAST; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION; INTERLEUKIN-12; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; OSTEOCLASTS; POLY I-C; RANK LIGAND; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84925691331     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24891     Document Type: Article

References (30)

1. Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL,. 1997. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest 100: 1557-1565.
2. Akira S, Uematsu S, Takeuchi O,. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
3. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA,. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
4. Amcheslavsky A, Bar-Shavit Z,. 2006. Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides. J Cell Physiol 207: 244-250.
5. Amcheslavsky A, Bar-Shavit Z,. 2007. In vivo activation of toll-like receptor 9 modulates osteoclastogenesis. J Bone Miner Res 22 (S1): s151.
6. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L,. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390: 175-179.
7. Bachmann MF, Wong BR, Josien R, Steinman RM, Oxenius A, Choi Y,. 1999. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J Exp Med 189: 1025-1031.
8. Bar-Shavit Z,. 2008. Taking a Toll on the bones: regulation of bone metabolism by innate immune regulators. Autoimmunity 41: 195-203.
9. Hayashi S, Yamada T, Tsuneto M, Yamane T, Takahashi M, Shultz LD, Yamazaki H,. 2003. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha. J Immunol 171: 5130-5139.
10. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S,. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
11. Henderson B, Nair SP,. 2003. Hard labour: bacterial infection of the skeleton. Trends Microbiol 11: 570-577.
12. Ilievski V, Hirsch E,. 2010. Synergy between viral and bacterial toll-like receptors leads to amplification of inflammatory responses and preterm labor in the mouse. Biol Reprod 83: 767-773.
13. Ji JD, Park-Min KH, Shen Z, Fajardo RJ, Goldring SR, McHugh KP, Ivashkiv LB,. 2009. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors. J Immunol 183: 7223-7233.
14. Kikuchi T, Matsuguchi T, Tsuboi N, Mitani A, Tanaka S, Matsuoka M, Yamamoto G, Hishikawa T, Noguchi T, Yoshikai Y,. 2001. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll- like receptors. J Immunol 166: 3574-3579.
15. Krieg AM,. 2002. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20: 709-760.
16. Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, Athanasou NA,. 2003. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 32: 1-7.
17. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ,. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
18. Nagata N, Kitaura H, Yoshida N, Nakayama K,. 2003. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population. Bone 33: 721-732.
19. Paul-Clark MJ, McMaster SK, Belcher E, Sorrentino R, Anandarajah J, Fleet M, Sriskandan S, Mitchell JA,. 2006. Differential effects of Gram-positive versus Gram-negative bacteria on NOSII and TNFalpha in macrophages: role of TLRs in synergy between the two. Br J Pharmacol 148: 1067-1075.
20. Takami M, Kim N, Rho J, Choi Y,. 2002. Stimulation by Toll-like receptors inhibits osteoclast differentiation. J Immunol 169: 1516-1523.
21. Takeshita S, Kaji K, Kudo A,. 2000. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res 15: 1477-1488.
22. Van Zant G,. 1984. Studies of hematopoietic stem cells spared by 5- fluorouracil. J Exp Med 159: 679-690.
23. Wang ZQ, Ovitt C, Grigoriadis AE, Möhle-Steinlein U, Rüther U, Wagner EF,. 1992. Bone and haematopoietic defects in mice lacking c-fos. Nature 360: 741-745.
24. West AP, Koblansky AA, Ghosh S,. 2006. Recognition and signaling by Toll-like receptors. Annu Rev Cell Dev Biol 22: 409-437.
25. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett FS, III, Frankel WN, Lee SY, Choi Y,. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c- Jun N-terminal kinase in T cells. J Biol Chem 272: 25190-25194.
26. Yi AK, Peckham DW, Ashman RF, Krieg AM,. 1999. CpG DNA rescues B cells from apoptosis by activating NF-kB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway. Int Immunol 11: 2015-2024.
27. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S,. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442-444.
28. Zou W, Bar-Shavit Z,. 2002. Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 17: 1211-1218.
29. Zou W, Hakim I, Tschoep K, Endres S, Bar-Shavit Z,. 2001. Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. J Cell Biochem 83: 70-83.
30. Zou W, Schwartz H, Endres S, Hartmann G, Bar-Shavit Z,. 2002. CpG oligonucleotides: novel regulators of osteoclast differentiation. FASEB J 16: 274-282.